The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013

Importance:It is important to understand the magnitude and distribution of the economic burden of prescription opioid overdose, abuse, and dependence to inform clinical practice, research, and other decision makers. Decision makers choosing approaches to address this epidemic need cost information to evaluate the cost effectiveness of their choices. Objective:To estimate the economic burden of prescription opioid overdose, abuse, and dependence from a societal perspective. Design, Setting, and Participants:Incidence of fatal prescription opioid overdose from the National Vital Statistics System, prevalence of abuse and dependence from the National Survey of Drug Use and Health. Fatal data are for the US population, nonfatal data are a nationally representative sample of the US civilian noninstitutionalized population ages 12 and older. Cost data are from various sources including health care claims data from the Truven Health MarketScan Research Databases, and cost of fatal cases from the WISQARS (Web-based Injury Statistics Query and Reporting System) cost module. Criminal justice costs were derived from the Justice Expenditure and Employment Extracts published by the Department of Justice. Estimates of lost productivity were based on a previously published study. Exposure:Calendar year 2013. Main Outcomes and Measures:Monetized burden of fatal overdose and abuse and dependence of prescription opioids. Results:The total economic burden is estimated to be $78.5 billion. Over one third of this amount is due to increased health care and substance abuse treatment costs ($28.9 billion). Approximately one quarter of the cost is borne by the public sector in health care, substance abuse treatment, and criminal justice costs. Conclusions and Relevance:These estimates can assist decision makers in understanding the magnitude of adverse health outcomes associated with prescription opioid use such as overdose, abuse, and dependence.

[1]  Grant T. Baldwin,et al.  CDC grand rounds , 2012 .

[2]  H. Birnbaum,et al.  The Economic Burden of Diagnosed Opioid Abuse Among Commercially Insured Individuals , 2014, Postgraduate medicine.

[3]  E. Wittenberg,et al.  Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population. , 2016, Addiction.

[4]  Shana Hertz Hattis.  Crime in the United States , 2013 .

[5]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[6]  Matt Schiller,et al.  Societal costs of prescription opioid abuse, dependence, and misuse in the United States. , 2011, Pain medicine.

[7]  T. Miller,et al.  Prescription Drug Abuse and Workplace Absenteeism: Evidence from the 2008–2012 National Survey on Drug Use and Health , 2015 .

[8]  Christopher M. Jones,et al.  CDC Grand Rounds: Prescription Drug Overdoes - A U.S. Epidemic , 2012 .

[9]  G. Oster,et al.  Economic Costs of Nonmedical Use of Prescription Opioids , 2011, The Clinical journal of pain.

[10]  Alan G. White,et al.  Estimated Costs of Prescription Opioid Analgesic Abuse in the United States in 2001: A Societal Perspective , 2006, The Clinical journal of pain.

[11]  S. Strassels,et al.  Economic Burden of Prescription Opioid Misuse and Abuse , 2009, Journal of managed care pharmacy : JMCP.

[12]  Karin A Mack,et al.  Pharmaceutical overdose deaths, United States, 2010. , 2013, JAMA.

[13]  C. E. Becker.  Drug Abuse in the United States , 1983 .

[14]  Kurt V. Krueger,et al.  Economic Productivity by Age and Sex: 2007 Estimates for the United States , 2009, Medical care.

[15]  A. Culyer.  Encyclopedia of health economics , 2014 .

[16]  Leonard J. Paulozzi,et al.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.

[17]  T. Coughlin.  Uncompensated Care for the Uninsured in 2013: A Detailed Examination , 2014 .

[18]  W. Manning.  Modeling Cost and Expenditure for Healthcare , 2014 .